로딩 중…
지수 로딩 중…
Cellromax Science Co., Ltd.
471820· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩4,600-0.33%
2026-06-19
Price Chart
Cellromax Science Co., Ltd.-5.35%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 51.99B KRW |
| Revenue | 20.98B KRW |
| Net Income | 2.65B KRW |
| Total Assets | 52.02B KRW |
| Net Assets | 47.63B KRW |
| Value | |
| P/E | 19.61x |
| P/B | 1.09x |
| P/S | 2.48x |
| EV/EBITDA | 20.93x |
| FCF Yield | 3.43% |
| Profitability | |
| ROE | 5.57% |
| ROA | 5.10% |
| Op. Margin | 11.11% |
| Revenue Growth | -20.42% |
| Earnings Growth | -30.54% |
| Financial Health | |
| Debt Ratio | 9.23% |
| FCF | 1.79B KRW |
| Cash | 3.21B KRW |
| Current Ratio | 4.87x |
| Net Debt/EBITDA | -1.38x |
| Dividend | |
| Div. Yield | 4.01% |
| Div. Growth | 12.12% |
| Performance | |
| 1Y Return | -5.35% |
| 1M Return | -3.36% |
| From 52W High | -40.18% |
| 1Y MDD | -34.24% |
| Trading | |
| Volume | 10,829 shares |
| Foreign Own. | 1.42% |
| Per Share | |
| EPS | 293 KRW |
| BPS | 4,266 KRW |